Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype

The val allele of the catechol-O-methyltransferase (COMT) val158met polymorphism has been linked with nicotine dependence and with cognitive performance in healthy volunteers. We tested the hypothesis that the val allele is a risk factor for altered brain function and cognition during nicotine abstinence as compared with the normal smoking state. Chronic smokers (n=33) were genotyped prospectively for the COMT polymorphism for balanced selection of met/met, val/met and val/val groups. A visual N-back working memory task was performed during two separate blood oxygen level-dependent (BOLD) functional magnetic resonance imaging sessions in counterbalanced order: (1) smoking as usual, and (2)⩾14 h confirmed abstinence. Significant genotype by session interactions were observed for BOLD signal in right dorsolateral prefrontal cortex (DLPFC; (P=0.0005), left DLPFC (P=0.02) and dorsal cingulate/medial prefrontal cortex (P=0.01) as well as for task reaction time (P=0.03). Smokers with val/val genotypes were more sensitive to the abstinence challenge than carriers of the met allele, with the greatest effects on BOLD signal and performance speed at the highest working memory load. These data suggest a novel brain–behavior mechanism that may underlie the increased susceptibility to nicotine dependence and smoking relapse associated with the COMT val allele. Exploration of the effects of COMT inhibitors as a possible smoking cessation aid in this group may be warranted.

[1]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[2]  John H. Krystal,et al.  Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers , 2005, Biological Psychiatry.

[3]  Kathryn M. McMillan,et al.  N‐back working memory paradigm: A meta‐analysis of normative functional neuroimaging studies , 2005, Human brain mapping.

[4]  M. Potenza,et al.  Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. , 2007, Drug and alcohol dependence.

[5]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[6]  D. Hatsukami,et al.  Effect of nicotine on the tobacco withdrawal syndrome , 1984, Psychopharmacology.

[7]  S. Siegel,et al.  Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice , 2005, The Journal of Neuroscience.

[8]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[9]  S J Heishman,et al.  Effect of nicotine on brain activation during performance of a working memory task , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Meco,et al.  Cognitive improvement during Tolcapone treatment in Parkinson's disease , 1997, Journal of Neural Transmission.

[12]  David Bartrés-Faz,et al.  Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects , 2007, NeuroImage.

[13]  Michael F Egan,et al.  Tolcapone Improves Cognition and Cortical Information Processing in Normal Human Subjects , 2007, Neuropsychopharmacology.

[14]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[15]  Monique Ernst,et al.  Previously Published Works Ucla Title: Brain Activity in Cigarette Smokers Performing a Working Memory Task: Effect of Smoking Abstinence Brain Activity in Cigarette Smokers Performing a Working Memory Task: Effect of Smoking Abstinence Ψ Running Title: Brain Activity in Smokers , 2022 .

[16]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Karayiorgou,et al.  Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice , 2002, The European journal of neuroscience.

[18]  Eve C. Johnstone,et al.  Relationship of Catechol-O-Methyltransferase Variants to Brain Structure and Function in a Population at High Risk of Psychosis , 2007, Biological Psychiatry.

[19]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[20]  S. Siegel,et al.  Translational research in medication development for nicotine dependence , 2007, Nature Reviews Drug Discovery.

[21]  Kenneth R. Pugh,et al.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency , 2006, Psychopharmacology.

[22]  K. Shokat,et al.  Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure , 2006, Science.

[23]  J. Gläscher,et al.  Gene–gene interaction associated with neural reward sensitivity , 2007, Proceedings of the National Academy of Sciences.

[24]  Mark S. Cohen,et al.  Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. , 2006, Addictive behaviors.

[25]  Jürgen Gallinat,et al.  COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits , 2006, NeuroImage.

[26]  T. Robbins,et al.  Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls , 2007, Molecular Psychiatry.

[27]  Mark S. Cohen,et al.  Effects of cigarette smoking and abstinence on stroop task performance , 2007, Psychopharmacology.

[28]  Caryn Lerman,et al.  Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. , 2005, Journal of substance abuse treatment.

[29]  Thomas E. Nichols,et al.  Impact of complex genetic variation in COMT on human brain function , 2006, Molecular Psychiatry.

[30]  M. Munafo,et al.  Association of COMT Val108/158Met genotype with smoking cessation , 2008, Pharmacogenetics and genomics.

[31]  Joseph A. Gogos,et al.  Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum , 2007, The Journal of Neuroscience.

[32]  R. Coppola,et al.  Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.

[33]  Marcus R. Munafò,et al.  Meta-Analysis of the Cognitive Effects of the Catechol-O-Methyltransferase Gene Val158/108Met Polymorphism , 2008, Biological Psychiatry.

[34]  Scott A Huettel,et al.  Abstinence-Induced Changes in Self-Report Craving Correlate with Event-Related fMRI Responses to Smoking Cues , 2005, Neuropsychopharmacology.

[35]  Terry E. Goldberg,et al.  Genetic Variation in Catechol-O-Methyltransferase: Effects on Working Memory in Schizophrenic Patients, Their Siblings, and Healthy Controls , 2008, Biological Psychiatry.

[36]  Stephen M. Smith,et al.  Temporal Autocorrelation in Univariate Linear Modeling of FMRI Data , 2001, NeuroImage.

[37]  Robin M. Chan,et al.  Working memory for complex figures: an fMRI comparison of letter and fractal n-back tasks. , 2002, Neuropsychology.

[38]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[39]  Edythe D London,et al.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. , 2006, Archives of general psychiatry.

[40]  Ming D. Li,et al.  Significant Association of Catechol-O-Methyltransferase (COMT) Haplotypes with Nicotine Dependence in Male and Female Smokers of Two Ethnic Populations , 2006, Neuropsychopharmacology.

[41]  Tommaso Scarabino,et al.  Additive Effects of Genetic Variation in Dopamine Regulating Genes on Working Memory Cortical Activity in Human Brain , 2006, The Journal of Neuroscience.

[42]  C. Pomerleau,et al.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. , 1994, Addictive behaviors.

[43]  S. David,et al.  Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.

[44]  T. Rebbeck,et al.  Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women , 2005, Pharmacogenetics and genomics.

[45]  David C. Van Essen,et al.  Application of Information Technology: An Integrated Software Suite for Surface-based Analyses of Cerebral Cortex , 2001, J. Am. Medical Informatics Assoc..

[46]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[47]  Edward E. Smith,et al.  A parametric study of prefrontal cortex involvement in human working memory , 1996, NeuroImage.

[48]  I. Stolerman,et al.  Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats , 2007, Pharmacology Biochemistry and Behavior.